Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 9/20 | 0.51 |
| ▸ | AVPR1B | P47901 | 2/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4744422 | 0.96 | AVPR1B (0.52) | HRH3AVPR1BSIGMAR1 | |
| SCHEMBL4741958 | 0.89 | HRH3 (0.53) | HRH3SIGMAR1BCHEACHE | |
| SCHEMBL4744392 | 0.88 | HRH3 (0.58) | HRH3BCHEACHEMAOB | |
| SCHEMBL4742594 | 0.88 | HRH3 (0.56) | HRH3BCHEACHEMAOB | |
| SCHEMBL4742644 | 0.87 | HRH3 (0.52) | HRH3SIGMAR1BCHEACHE | |
| SCHEMBL4743420 | 0.87 | HRH3 (0.51) | HRH3AVPR1BSIGMAR1BCHEACHE | |
| SCHEMBL4742556 | 0.86 | HRH3 (0.54) | HRH3SIGMAR1BCHEACHE | |
| SCHEMBL4741928 | 0.86 | HRH3 (0.54) | HRH3SIGMAR1BCHEACHE | |
| SCHEMBL4744494 | 0.85 | HRH3 (0.50) | HRH3SIGMAR1BCHEACHE | |
| SCHEMBL4744473 | 0.85 | HRH3 (0.50) | HRH3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008107321-A1 | HETEROCYCLIC COMPOUNDS USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS | CEREP (FR) | 2008-09-12 | — | — | WO | claimed |
| WO-2008107321-A1 | HETEROCYCLIC COMPOUNDS USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS | CEREP (FR) | 2008-09-12 | — | — | WO | disclosed |